In addition, a type-1 IFN signature in both human AD patients and APPSWE/PS1ΔE9 mice is evident and removal IFNAR1 confers protection against soluble Aβ1-42-induced toxicity in primary cultured neurons [64]. This evidence concerns the gene IFNAR1 and Alzheimer disease.